CRISPR clear? Dimeric Cas9-Fok1 nucleases improve genome-editing specificity.
CRISPR clear? Dimeric Cas9-Fok1 nucleases improve genome-editing specificity.
复制标题
DOI:
10.1016/j.gendis.2014.08.004
复制
发表时间:
2014-09
期刊:
影响因子:
6.8
通讯作者:
He, Tong-Chuan
中科院分区:
文献类型:
--
作者:
Zhang, Hongmei;Yan, Zhengjian;Li, Melissa;Peabody, Michael;He, Tong-Chuan
Bacteria and archaea have been known for decades having evolved adaptive immune defenses called clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) systems to degrade foreign nucleic acids. Recently, these RNA-guided Cas9 nucleases derived from CRISPR/Cas systems have shown promise in transforming our ability to edit mammalian genomes. 1 While zinc-finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs) have shown similar promise, the ease of producing targeting RNAs over the generation of unique sequence-directed nucleases to guide site-specific modifications makes the CRISPR/Cas9 system an appealing method for genome editing. A short guide RNA (sgRNA) can direct Cas9 to a specific genomic sequence where it induces doublestrand breaks that, when imperfectly repaired, yield mutations. 1 Cas9 can also catalyze gene replacement through homologous recombination. 1 Undoubtedly, Cas9-mediated genome editing and regulation should have transformative potential for basic science, genome engineering and therapeutics. 1